BioLife Solutions (BLFS) Tops Q1 EPS by 13c, Beats on Revenue

Go back to BioLife Solutions (BLFS) Tops Q1 EPS by 13c, Beats on Revenue

BioLife Solutions Reports First Quarter 2024 Financial Results

May 9, 2024 4:03 PM EDT

Cell Processing revenue increased 10% sequentially to $16.2 million

GAAP gross margin of 38% and net loss of $10.2 million

Non-GAAP adjusted gross margin expands from 40% to 53% and adjusted EBITDA of $3.6 million or 13% ex-GCI freezers

Conference call begins at 4:30 p.m. Eastern time today

 

BOTHELL, Wash., May 9, 2024 /PRNewswire/ --... More